The Global Dermatology Imaging Devices Market size is expected to reach $5.4 billion by 2030, rising at a market growth of 12.5% CAGR during the forecast period.
Digital photographic imaging allows dermatologists to capture high-quality images of skin conditions for documentation and record-keeping purposes. Thus, the digital photographic imaging segment acquired $560.2 million in 2022. Digital photographic imaging allows dermatologists to capture high-quality images of skin conditions for documentation and record-keeping purposes.
The global rise in aesthetic consciousness and the desire for youthful and healthy-looking skin contribute to the growing demand for cosmetic dermatology procedures. Therefore, the market is expanding significantly due to the rise in cosmetic dermatology procedures.
Additionally, public health campaigns and awareness initiatives focus on educating the population about the risks of skin cancers and the significance of early detection. Thus, because of the growing emphasis on early detection of skin cancers, the market is anticipated to increase significantly.
Further, The market, like other industries, experienced disruptions in the supply chain during the pandemic. Challenges such as production delays, transportation issues, and shortages of certain components affected the availability of devices. Thus, the COVID-19 pandemic had a moderate effect on the market.
However, Smaller dermatology practices and clinics may struggle to afford the upfront investment required for advanced imaging technologies. Thus, high initial costs can slow down the growth of the market.
Digital photographic imaging allows dermatologists to capture high-quality images of skin conditions for documentation and record-keeping purposes. Thus, the digital photographic imaging segment acquired $560.2 million in 2022. Digital photographic imaging allows dermatologists to capture high-quality images of skin conditions for documentation and record-keeping purposes.
The global rise in aesthetic consciousness and the desire for youthful and healthy-looking skin contribute to the growing demand for cosmetic dermatology procedures. Therefore, the market is expanding significantly due to the rise in cosmetic dermatology procedures.
Additionally, public health campaigns and awareness initiatives focus on educating the population about the risks of skin cancers and the significance of early detection. Thus, because of the growing emphasis on early detection of skin cancers, the market is anticipated to increase significantly.
Further, The market, like other industries, experienced disruptions in the supply chain during the pandemic. Challenges such as production delays, transportation issues, and shortages of certain components affected the availability of devices. Thus, the COVID-19 pandemic had a moderate effect on the market.
However, Smaller dermatology practices and clinics may struggle to afford the upfront investment required for advanced imaging technologies. Thus, high initial costs can slow down the growth of the market.
By End-use Analysis
On the basis of end use, the market is divided into hospitals, dermatology centers, and specialty clinics. In 2022, the hospitals segment registered a 45% revenue share in the market. Precise visualization of lesion boundaries and structures helps dermatologists accurately target biopsy sites, ensuring that samples are representative of the affected tissue and improving the diagnostic yield.
By Modality Analysis
By modality, the market is categorized into digital photographic imaging, optical coherence tomography (OCT), dermatoscope, high frequency ultrasound, and others. The optical coherence tomography (OCT) segment procured 10% revenue share in the market in 2022.By Application Analysis
Based on application, the market is classified into skin cancers, inflammatory dermatoses, plastic & reconstructive surgery, and others. In 2022, the skin cancers segment witnessed 49% revenue share in the market. Dermatology imaging devices guide skin biopsies and surgical procedures.By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating 50% revenue share. The North American population's interest in cosmetic dermatology procedures has led to integrating imaging devices into aesthetic practices.Recent Strategies Deployed in the Market
- Mar-2024: FotoFinder Systems GmbH signed an agreement to acquire DermLite LLC, a company specializing in dermatology diagnostic devices, particularly dermoscopes, for skin examination. Through this acquisition, FotoFinder would be able to accelerate the development of innovative technologies to promote early detection and precise diagnosis of skin cancer globally.
- Jan-2023: GE HealthCare Technologies, Inc. took over IMACTIS, a software company specializing in medical imaging and computer-aided diagnosis solutions. Through this acquisition, GE HealthCare would be able to enhance workflow for interventional radiologists and hospitals, enhancing procedural precision while reducing patient and physician radiation exposure and procedure duration, through IMACTIS's innovative navigation solution for image-guided percutaneous procedures, aiming to improve patient outcomes by minimizing variability and enhancing reproducibility in both simple and complex procedures.
- Feb-2022: FUJIFILM VisualSonics, Inc. signed a partnership with PIUR IMAGING, a cutting-edge company specializing in advanced imaging technology. Through this partnership, VisualSonics would empower its users to introduce a fresh perspective in visualizing pathological tissue across a range of clinical applications.
- Dec-2021: Courage + Khazaka electronic GmbH launched MoistureMap MM 200, a cutting-edge skin moisture measurement device. The device provides visual data regarding the hydration distribution and micro-topography of skin and other tissues such as textiles and plants. Moreover, it also generates 3D images and high-resolution visuals for permittivity analysis, facilitating comparison between two regions of interest within a single image.
- Jun-2021: FotoFinder Systems GmbH came into partnership with QuantifiCare, a leading provider of 3D imaging solutions for the aesthetic and medical industries. Through this partnership, both companies would offer their customers with study locations a complete mobile solution for capturing, reviewing, and promptly transferring high-resolution digital dermoscopic images into the clinical trial process.
List of Key Companies Profiled
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Canfield Scientific, Inc.
- FotoFinder Systems GmbH
- Courage + Khazaka electronic GmbH
- FUJIFILM VisualSonics, Inc. (Fujifilm Holdings Corporation)
- Longport, Inc.
- Michelson Diagnostics Ltd
- DRAMINSKI S. A.
- Cortex Technology ApS
Market Report Segmentation
By End-use- Hospitals
- Dermatology Centers
- Specialty Clinics
- Dermatoscope
- Digital Photographic Imaging
- Optical Coherence Tomography (OCT)
- High Frequency Ultrasound
- Others
- Skin Cancers
- Inflammatory Dermatoses
- Plastic & Reconstructive Surgery
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Global Dermatology Imaging Devices Market by End-use
Chapter 6. Global Dermatology Imaging Devices Market by Modality
Chapter 7. Global Dermatology Imaging Devices Market by Application
Chapter 8. Global Dermatology Imaging Devices Market by Region
Chapter 9. Company Profiles
Companies Mentioned
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- Canfield Scientific, Inc.
- FotoFinder Systems GmbH
- Courage + Khazaka electronic GmbH
- FUJIFILM VisualSonics, Inc. (Fujifilm Holdings Corporation)
- Longport, Inc.
- Michelson Diagnostics Ltd
- DRAMINSKI S. A.
- Cortex Technology ApS
Methodology
LOADING...
